Bruce F. Wesson, Director at ACURA PHARMACEUTICALS, INC (ACUR), bought 14,904 shares at $3.01 ($45K) on 2011-08-19, disclosed to the SEC on 2011-08-23.
Open-market purchase of $45k ACUR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.94 | 5 | $15 | 0.0% |
| 2 | $2.97 | 200 | $594 | 1.3% |
| 3 | $2.98 | 500 | $1K | 3.3% |
| 4 | $2.98 | 1,822 | $5K | 11.9% |
| 5 | $3.00 | 219 | $657 | 1.4% |
| 6 | $3.01 | 1,053 |
| $3K |
| 7.0% |
| 7 | $3.02 | 3,000 | $9K | 19.9% |
| 8 | $3.02 | 2,900 | $9K | 19.3% |
| 9 | $3.03 | 900 | $3K | 6.0% |
| 10 | $3.11 | 1,901 | $6K | 13.0% |
| 11 | $3.17 | 300 | $951 | 2.1% |
| 12 | $3.17 | 904 | $3K | 6.3% |
| 13 | $3.18 | 1,200 | $4K | 8.4% |
| Total | $3.05 avg | 14,904 | $45K | 100% |
| Filing → |
| ACUR | BUY | 2014-05-16 | $68K | — | Filing → |
| MDAS | SELL | 2013-11-22 | $1.2M | — | Filing → |
| DSCI | BUY | 2011-11-28 | $75K | — | Filing → |